Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • Support on the Diabetes Journey
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Nutrisystem.com
Latest
Popular
Top Rated
Diabetes Archives
Print | Email | Share | Comments (1)

Brits Report That Hypertension Drug Lowers Retinopathy Risk in Type 1s

Oct 6, 2008

Candesartan not only reduced the occurrence of retinopathy in patients who entered the study free of the condition, but also slowed the progression of the disease in those who already had it.

According to the British public health organization Diabetes UK, a four-year study has shown that the drug candesartan reduces the chances of people with type 1 diabetes developing retinopathy by almost 20 percent.

These findings could lead to the first-time use of a drug therapy to treat retinopathy. Retinopathy, a common consequence of diabetes in which blood vessels in the eye begin to leak and then scar from the effects of high blood sugar, is currently treated with surgery or laser therapy.

Candesartan is a hypertension treatment commonly sold under the trade names Amias, Atacand, Blopress, and Ratacand by the drug companies AstraZeneca and Takeda Pharmaceuticals. 

The researchers, from Imperial College in London, tracked more than 1,400 patients with type 1 diabetes, administering candesartan to 711 of them and a placebo to the remaining 710. 

They noted that the drug not only reduced the occurrence of retinopathy in patients who entered the study free of the condition, but also slowed the progression of the disease in those who already had it.


Categories: Blood Sugar, Diabetes, Research, Type 1 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Oct 6, 2008

Nutrisystem.com
©1991-2012 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.